Product Information

CLOBETASOL PROP 0.05% FOAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.4268 per GM under NDC 68462060827. Its NADAC has been published 394 times since May 8, 2019.

FDA first approved this application on Feb 15, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOBETASOL PROP 0.05% FOAM

clobetasol propionate
$0.4268per GM

Strength

.5 mg/g

NDC

68462060827

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CLOBETASOL PROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210809

FDA Approved

2/15/2019

TE Code

AB1

On Market Since

2/16/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for CLOBETASOL PROP 0.05% FOAM has been published 394 times since May 8, 2019, and over the history we have for it it has declined 74.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4268 per GM
All-time high$1.9202 (Oct 16, 2019)
All-time low$0.2433 (Nov 20, 2024)
52-week high$0.4493
52-week low$0.3054
Median price$0.4655
Average price$0.6218
Largest weekly change+56.1% (Jun 19, 2024)
Weeks tracked394
Tracking sinceMay 8, 2019

Price History

1W

-2.1%

1M

-2.1%

3M

+13.4%

6M

+39.7%

1Y

+6.2%

3Y

-1.1%

5Y

-28.8%

All

-74.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOBETASOL PROP 0.05% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL PROP 0.05% FOAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.4268 per GM (NDC 68462060827), effective Nov 18, 2026.

How has the price of CLOBETASOL PROP 0.05% FOAM changed over time?

Over the history we have for it, the NADAC for CLOBETASOL PROP 0.05% FOAM has declined 74.9%. It has been tracked across 394 weekly CMS publications since May 8, 2019.

What are the highest and lowest recorded NADAC prices for CLOBETASOL PROP 0.05% FOAM?

Since May 8, 2019, the NADAC for CLOBETASOL PROP 0.05% FOAM has ranged from a low of $0.2433 (Nov 20, 2024) to a high of $1.9202 (Oct 16, 2019), with a median of $0.4655 per GM.

Are there cheaper alternatives to CLOBETASOL PROP 0.05% FOAM?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL PROP 0.05% FOAM, is $0.3674 per GM — about 14% below CLOBETASOL PROP 0.05% FOAM.

Who manufactures CLOBETASOL PROP 0.05% FOAM?

CLOBETASOL PROP 0.05% FOAM (NDC 68462060827) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.